Upgrade to SI Premium - Free Trial

RXO, Inc. (RXO) PT Raised to $18 at Goldman Sachs

May 8, 2026 6:44 AM
Goldman Sachs analyst Jordan Alliger raised the price target on RXO, Inc. (NYSE: RXO) to $18.00 (from $13.00) while maintaining a Neutral rating.

Categories

Analyst PT Change